Parsatuzumab (Anti-EGFL7)
Product Specifications
CAS Number
1312797-14-0
Synonyms
Anti-EGFL7; RG 7414
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940204-100 1x 100 µL
Complement C4d (C4D204), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040525-500 1x 500 µL
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741037-100 1x 100 µL
CD44 Standard (DF1485), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881384-100 1x 100 µL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1384), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041475-100 1x 100 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1475), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details